Synopsis of recent research by authors named "Qing-You Meng"
- Qing-you Meng's research primarily focuses on the therapeutic applications of vascular endothelial progenitor cells (EPCs) and various approaches in managing venous thrombotic conditions, including deep vein thrombosis and chronic venous thrombosis, often employing gene therapy techniques like VEGF165 overexpression.
- The studies demonstrate the efficacy of transplantation of gene-modified EPCs in alleviating endothelial injury and promoting vascular repair following procedures such as deep vein thrombectomy, showcasing significant improvements in cellular outcomes and overall vascular health.
- Additionally, Meng has investigated the safety and efficacy of catheter-directed thrombolysis and the implications of various treatment methods, including low dosage urokinase therapy and endovascular interventions, addressing gaps in existing treatment protocols for deep venous thrombosis and similar conditions.
